First food: business of taste
Good Food is First Food. It is not junk food. It is the food that connects nature and nutrition with livelihoods. This food is good for our health; it comes from the rich biodiversity of our regions; it
India
-
Schemes for poor fine, but what's the definition of poverty?
The UPA government is yet to set up an expert group to undertake a survey to identify people below the poverty line (BPL), even as the 11th Plan is already underway. The survey is normally conducted by the Ministry of Rural Development (MoRD) in the first year of every Plan period. However with the government's delay in setting up the group, work is expected to begin only in 2009, the third year of the 11th Plan. In fact, the government is yet to set the criteria to measure poverty for the 11th Plan. In the last three Plans, different criteria have been used to identify the poor
-
Chickpea, sorghum: India sends seeds to Noah's Food Ark' deep in the Arctic
Halfway between the northern coast of Norway and the North Pole in an archipelago called Svalbard, three enormous caverns have been blasted 130 m into the permafrost. Called the doomsday vault, it will be a Noah's Ark of food in the event of a global catastrophe. Among the world's 45,000 most important seeds stored in this Svalbard Global Seed Vault, there will be quite a bit of India too. Seeds of sorghum, pearl millet, chickpea, pigeonpea, groundnut and six small millets will be transferred by the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) from its headquarters in Patencheru, near Hyderabad to this location, 1000 km from the Arctic. William Dar, Director General of ICRISAT, is at Svalbard for the opening celebrations tomorrow. He will join European Commission President Jose Manuel Barroso and Nobel Peace Prize-winning environmentalist Wangari Mathai in this global initiative. Norway is footing the $8.9-million bill for building the Arctic archipelago where, ironically, no crops grow. Secured behind an airlock door, the three airtight chambers can house duplicates of samples from the world's more than 1,400 existing seed banks. The Norwegian archipelago was selected for its inhospitable climate as well as its remote location. The seeds of wheat, maize, oats and other crops will be stored at a constant temperature of minus 18 degrees Celsius, and even if the freezer system fails, the permafrost will ensure that temperatures never rise above 3.5 degrees Celsius below freezing. This project is important as some of the world's biodiversity has already disappeared, with gene vaults in both Iraq and Afghanistan destroyed by war and a seed bank in the Philippines annihilated by a typhoon. Seed banks have begun contributing: potato seeds from Peru; 30,000 samples of different beans from Colombia; 47,000 seed samples of wheat and 10,000 types of maize from Mexico and thousands of rice varieties from Philippines. Pakistan and Kenya, both wracked by serious unrest, have sent seed collections too. By the time of the inauguration on Tuesday, the Svalbard Global Seed Vault will hold some 250,000 samples, which will remain the property of their countries of origin. According to Dar, ICRISAT's participation adds a special significance to the project
-
Seeds of change
The NSC has transformed itself from the usual non-profit-earning PSU into a vibrant entity. Private sector seed companies have, till now, had a virtual monopoly over the production and sale of seeds, mostly hybrid seeds, of high-value crops. This was chiefly because the public sector seed producers, besides being fewer in number, remained focused right from the beginning on the production of seeds of low-value but high-volume crops (basically cereals), where profits were low though the quantities to be handled were large. Besides, public sector units (PSUs) made little attempt to keep pace with time. However, the much-needed change in the public seed sector is coming about now with the largest player, the National Seeds Corporation (NSC), adopting a corporate culture and deploying state-of-the-art technology to produce seeds even of high-value crops and hybrids. Indeed, as could be expected, this change in the work culture has transformed the NSC from the usual non-profit-earning PSU into a vibrant entity striving to find a place among the mini-Ratnas, if not the Navratnas. The headquarters of the NSC and four of its regional units in Bhopal, Jaipur, Secunderabad and Bangalore, have already acquired the ISO 9001-2000 certificate and the remaining regional units are in the process of doing so. No wonder then that, after a gap of 32 years, the NSC paid a 5 per cent dividend, amounting to a little over Rs 1 crore, to the government in November last. This was made possible by a massive 46 per cent growth in business in the past one year alone. Its post-tax profits jumped by a whopping 200 per cent in 2006-07. Indeed, the man behind this incredible transformation is the present chairman and managing director B B Pattanaik. "I would be able to declare a much higher dividend for the current year,' asserts an enthusiastic Pattanaik. He has not only motivated the aging employees of this 45-year-old corporation for better performance but has also taken several new initiatives to be in a position to rub shoulders with the well-run private sector seed companies, many of which now have business tie-ups with the NSC. "I am not interested in increasing competition with the corporate houses; I am more for partnerships,' says Pattanaik. About a dozen big houses, including some multinational companies like Monsanto and Cargill and domestic players like ITC, ECL Agro-Tech and Sheel Biotech, have forged strategic business alliances with the NSC. Most of these companies use the vast marketing network of the NSC for the sale of their seeds and other farm inputs. The Indian Oil Corporation, on the other hand, sells the NSC seeds through its network of Kisan Seva Kendras (farmers' service centres). Significantly, the NSC is now very much into the production of hybrid seeds, organic seeds and even tissue culture plantlets. It is multiplying the seeds of mustard hybrid DMH-1-DHARA evolved through biotechnological interventions by the Delhi University; as also those of the pigeon pea (arhar) hybrid, ICPH 2671, evolved by the Hyderabad-based International Crops Research Institute for Semi-arid Tropics (ICRISAT). Besides, the NSC would soon begin supplying gladiolus bulbs for flower cultivation. The NSC's tissue culture unit with a capacity to churn out annually about two lakh test tube-raised plantlets for propagation of the banana is coming up in Bhubaneswar and may become operational by the next month. For research and development back-up, the NSC gets support from the vast agricultural research network of the Indian Council of Agricultural Research (ICAR) and the state agriculture universities. This helps the NSC to add, on an average, around 20 new varieties and hybrids to its product range every year. Significantly, the NSC is now playing a catalytic role in the expansion of seed production, processing and storage infrastructure in the private sector under a government scheme involving 25 per cent subsidy for this purpose. About 120 projects for the creation of seed processing capacity worth 23 lakh quintals and seed storage capacity of 9 lakh quintals have already been approved. A total subsidy of Rs 6.94 crore would be paid to the private sector companies which are creating these facilities. For involving more and more farmers in the relatively more lucrative seed production business, the NSC is facilitating the provision of loans to them from the State Bank of India. Besides, it is ploughing back about 2 per cent of its own profits into the activities related to seed production by farmers and other measures as part of its corporate social responsibility initiative.
-
Budget 2008-09: The burden of expectations
N. Ravi The challenge before the Finance Minister in preparing a pre-election budget is to balance the minimal tax sops needed to keep the markets in an upbeat mood with massive spending programmes that will find resonance with the electorate. Preparing for the election-eve budget, Finance Minister P. Chidambaram must have found the burden of expectations unusually high. Not only is he expected to provide the usual budgetary sops to please all but he is also called upon to correct the sense of drift that has come to mark the last one year of functioning of the United Progressive Alliance government and recapture the popular imagination. And this he has to accomplish without overly stretching either fiscal norms or his own credibility that will be called into question by a sudden show of solicitude at election time. Budgets are invariably characterised as pro-poor, pro-growth or pro-rich, depending on one's perspective and if such labels can normally be shrugged off, they become particularly critical at this time. In a sense, the Finance Minister will have to be riding the two horses of populism and fostering growth. For while this year's budget can be expected to lean heavily towards giveaways, it cannot ignore measures needed to sustain economic performance. True the mood of industry and the markets does not necessarily translate into the mood of the electorate as the National Democratic Alliance government found to its cost when its overdrawn
-
Chidambaram cannot afford a harsh budget
Ashok Dasgupta Elections are due in many State Assemblies this year P. Chidambaram With Assembly polls due in a number of States during the year-end and the general elections in 2009, it is a foregone conclusion that the Union budget for the next fiscal, to be presented by Finance Minister P. Chidambaram in three days from now, will not be a harsh one, even at worst. For the simple reason that over the last few weeks, the people's aspirations of deriving some benefits by way of budgetary goodies have been raised so high through statements by various functionaries of the Congress-led United Progressive Alliance (UPA) government and its coalition partners that anything not matching up to their expectations would perhaps be viewed as a great betrayal. And that's something that the ruling regime can ill afford, especially when the government is set to unveil its policy programmes and statement of accounts, the fifth and final in its current Lok Sabha term. In effect, the government will not only have to but also be seen as compensating the
-
Discharge-free green toilets to clean up tracks
Railway minister Lalu Prasad is embarking on a move to clean up the railway stations and cut down corrosion of tracks. The railways trains will have discharge-free green toilets in all the coaches by 2011-12. "Discharge from toilets of train has been the prime reason for poor sanitation facility at stations
-
Record foodgrain output in 2007-08'
Food grain production in 2007-08 is estimated at a record level of 219.32 million tonnes as per the second advance estimate. This is higher than the 217.28 million tonnes for 2006-07. This was stated by Union Agriculture Minister Sharad Pawar at a National Conference on Agriculture for Kharif Campaign here on Tuesday. Mr. Pawar said the rice production was estimated at 94.08 million tonnes, compared to 93.35 million tonnes the previous year. The production of coarse cereals was estimated at 36.09 million tonnes. The cotton production stood at 233.81 lakh bales in 2007-08, which, he termed a record. For 4 p.c. growth Pointing out that the government aimed at achieving 4 per cent growth in agriculture, Mr. Pawar said resource constraint would not be allowed to stand in the way of achieving this target. Necessary funds would be provided to States for all agricultural schemes. The target for agricultural growth in the XI Plan was fixed at 4 per cent per annum. To achieve this target, action on several areas was required. This included bringing technology to farmers, improving efficiency of investments, increasing systems support and rationalising subsidy, besides protecting food security concerns and fostering inclusiveness through group approach by which the poor would get better access to land, credit and skill, Mr. Pawar said. Directive to States The Minister asked the State governments to work out an action plan for implementing the National Policy for Farmers, keeping in view the grass roots level requirements. On maximising kharif output, he asked the States to popularise hybrid rice technology through demonstrations and availability of quality seeds.
-
Highlights: Cash surplus at record high
The Minister for Railways, Mr Lalu Prasad, flanked by the Ministers of State, Mr Naranbhai Rathwa (left), and Mr R.Velu, arriving to present the Rail Budget on Tuesday. Review of Performance: 2007-08
-
Focus on agriculture
The article on "Focus on agriculture' (Business Line, February 18) highlighted the need for giving importance to the agricultural sector in the context of its importance to the economy. The article focused on price levels of agricultural commodities in the background of the Government's concern for checking inflation. In this context, it is worth looking at the growth strategy adopted by Israel, a small country made up of predominantly desert and semi-arid land. Since its independence in 1948, it has been able to increase its agricultural production 16-fold, thanks to the synergies and co-operation between agricultural scientists, extension workers, farmers and service industries. Israeli farmers conserve water by constructing terraces in the hilly regions, which naturally holds water. Besides, drip irrigation techniques are used to reduce water consumption for agriculture. Also, use of optimal water, sunlight and air pressure increases productivity. Genetic technology and tissue culture have been employed to reduce the cropping time. Besides, techniques such as use of soil preparation machinery have increased soil fertility. Result: Higher production at low cost. This has enabled the country to export more than 70 per cent of its farm produce. What India requires is a marriage of superior cost-effective techniques and farming, akin to the Israeli model, to increase production at lesser cost. This will increase the profit margin of farmers and could be a solution to their economics-related problems. P. E. Muthu Mumbai
-
In The Pink Of Health
R&D is a fast evolving segment of Indian pharmaceutical industry. Innovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing the landscape of R&D. However, the potential is far greater and to aid the harnessing of this potential, the Times Group organised the ET Bio-Pharma Development Summit in Mumbai. Dr Swati Piramal, director, Nicholas Piramal, was the chairperson of the forum, with the keynote speaker being Dr Ted Bianco, director, Wellcome Trust. The highlight of the event was the special address delivered by Kapil Sibal, union minister for science and technology and earth sciences. Dr Piramal delivered the opening address to a house full of delegates. She highlighted the need of innovation in R&D and how India can excel in the same. Her address was followed by an interesting speech made by Dr Ted Bianco, director, Wellcome Trust, UK. He provided an insight into early stage R&D through translational research funding and management of intellectual property arising thereafter. Then, it was time for Mr Sibal's speech. He termed the new disease pathogens the terrorists of the 21st century and said there was an urgent need to safeguard public health. He also made a strong case for growth of R&D in case of Indian pharmaceutical industry and how it could be harnessed in India to provide affordable cure. The minister stressed on the need for a forward-looking drug policy and government subsidies to boost innovation in the country. Malvinder Singh, MD and CEO, Ranbaxy Laboratories, the speaker for the second session, gave a address on the future of generics. He informed that the global bio-generic industry was worth $60 billion today. Indian pharma industry can capitalize on this opportunity and grow to become $100 billion industry in the coming years. He pointed out that having 50 NCEs being produced by 15-20 companies is not economically sustainable. Industry needn't duplicate infrastructure as it would be feasible to unite through partnerships and collaborations, he said. He also stressed upon the need for an enabling regulatory framework, which moves away from the price control regime. He pointed out that at present, R&D done internally by the companies alone qualified for weighted deduction under section 35(2AB) of Income tax act. He urged that the government to facilitate innovation by extending this benefit to outsourced R&D as well. The third session was a panel discussion providing an HR perspective on strategies for human resource management. Dr Ganesh Shermon, partner & country head, human capital advisory services, KPMG India, Rajorshi Ganguli, director, HR, Dr Reddy's Laboratories, Sanjay Muthal, president, HR, Nicholas Piramal and Shiv Raman Dugal, chairman, Instiute of Clinical Research of India, were the distinguished speakers forming the panel. Various strategies needed to drive excellence in research and cross-functional areas were discussed. The next session emphasising on what's next in Indian bio-pharmaceuticals was moderated by Utkarsh Palnitkar, national head of health and science industry, Ernst & Young, India. One of the speakers - Dr Ramani Aiyer, chief scientific officer, Actis Biologics - highlighted the new trends in bio pharma. He also delved into the concepts of angiogenesis, gene therapy, recombinant proteins and follow-on biologics. Kavita Khanna, president, Bharat serums & Vaccines, was the next speaker in the session and gave her views on the way forward in publicprivate partnerships. She presented a case study on 'Kala Azaar' (Leishmaniasis), to explain how public private partnership was being proposed to eradicate the disease by 2010. Adnan Naseemullah, a student of university of California, Berkeley, was one of the invitees to the session. He spoke about the growth and development of the Indian pharmaceutical industry and highlighted the variations in research strategies followed by the industry. The post lunch session was a two-speaker special session held by Dr S K Gupta, dean and director, Institute of Clinical Research of India (ICRI) and Dr Anand Bidarkar, VP, Siro Clinpharm India. They delved into the various clinical research strategies to maange research and development in India. Dr Gupta provided the statistical data on the infrastructure which is available for clinical research in India and how can India emerge as a world-class destination for conducting quality clinical research. Dr Bidarkar explained how MNCs were taking advantage of Indian clinical R&D to shorten their drug development timelines. He also highlighted how Indian companies could look at outsourcing to overcome their competitive disadvantages. The concluding session of the day was the CEO round table. Presided by Dr Piramal, with Pratibha Pilgaonkar, CEO, Rubicon Research, Dr Naveen Rao, MD, Merck India and Dr Ajit Dangi, president and CEO, Danssen Consulting, being the other participants in the discussion. Dr Piramal posed various questions to the panel relating to scope of R&D in India, possibility of doing a Nano in pharma and cost of innovation. Dr Naveen Rao, MD, Merck India, expressed the need for big pharma companies to look at India and its cost-effective resources. He also stated that partnerships offered an attractive method of risk and reward sharing. Ms Pilgaonkar pointed out that SMEs in Indian pharma industry at an early stage need the support and funding from big players in the industry to become agents of research and innovation. Dr Dangi stressed on the need for world class intellectual property (IPR) regime, lowering of transaction costs and a liberal price policy in the country. Strengthening of the infrastructure of Drug Controller General of India, approval of various protocols for clinical trials, framing of laws on cloning and neutraceuticals were other issues discussed by the panel discussion. Dr Piramal projected that by 2010, India would have discovered at least five new drugs . Her personal bet on the cost of innovation of a new drug in India stood at less than $50 million. The session concluded after a question and answer session where the audience put forth their questions to the panelists.